LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 80

Search options

  1. Article ; Online: Autopsy Human Brain Dissection Protocol for Common Age-Related Neurodegenerative Disorders.

    Sonnen, Joshua A

    Methods in molecular biology (Clifton, N.J.)

    2022  Volume 2515, Page(s) 255–279

    Abstract: Age-related neurodegenerative disorders are common causes of dementia-associated morbidity and mortality in populations throughout the world. Standardized, protocol-based methods for the examination and diagnosis of these disorders allow direct ... ...

    Abstract Age-related neurodegenerative disorders are common causes of dementia-associated morbidity and mortality in populations throughout the world. Standardized, protocol-based methods for the examination and diagnosis of these disorders allow direct comparison between human cohorts and play a key role in understanding how these disorders impact our population. Further understanding of these protocols and harmonization with animal and in vitro investigative techniques is imperative to demonstrate relevance to human disease. The following is a concise protocol for the examination of human whole brain autopsy samples, with and without spinal cord, for the examination of neurodegenerative disorders. The following protocol is designed to provide samples appropriate for most neurodegenerative diseases. The collection of both fresh-frozen and formalin-fixed tissues is described.This guide presumes general knowledge of neuroanatomy of the human central nervous system. Tissue processing, detailed histological techniques and complete diagnostic examination of the brain is beyond the scope of this chapter; however, a limited evaluation appropriate for the evaluation of neurodegenerative disease is described here. Diagnostic protocols for the most common causes of dementia-associated, age-related neurodegenerative disorders are also summarized.
    MeSH term(s) Autopsy ; Brain/pathology ; Dementia/diagnosis ; Dementia/etiology ; Dementia/pathology ; Humans ; Neurodegenerative Diseases/diagnosis ; Neurodegenerative Diseases/pathology ; Spinal Cord/pathology
    Language English
    Publishing date 2022-07-01
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-2409-8_16
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Amyloid-PET in cerebral amyloid angiopathy: Detecting vascular amyloid deposits, not just blood.

    Raposo, Nicolas / Sonnen, Joshua A

    Neurology

    2017  Volume 89, Issue 14, Page(s) 1437–1438

    MeSH term(s) Amyloid/metabolism ; Amyloid beta-Peptides/metabolism ; Amyloidosis/diagnostic imaging ; Amyloidosis/pathology ; Humans ; Peripheral Vascular Diseases/diagnostic imaging ; Positron-Emission Tomography
    Chemical Substances Amyloid ; Amyloid beta-Peptides
    Language English
    Publishing date 2017-08-30
    Publishing country United States
    Document type Editorial
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/WNL.0000000000004548
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids.

    Tamaki, Yoshitaka / Ross, Jay P / Alipour, Paria / Castonguay, Charles-Étienne / Li, Boting / Catoire, Helene / Rochefort, Daniel / Urushitani, Makoto / Takahashi, Ryosuke / Sonnen, Joshua A / Stifani, Stefano / Dion, Patrick A / Rouleau, Guy A

    PLoS genetics

    2023  Volume 19, Issue 2, Page(s) e1010606

    Abstract: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder caused by progressive loss of motor neurons and there is currently no effective therapy. Cytoplasmic mislocalization and aggregation of TAR DNA-binding protein 43 kDa (TDP-43) ... ...

    Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder caused by progressive loss of motor neurons and there is currently no effective therapy. Cytoplasmic mislocalization and aggregation of TAR DNA-binding protein 43 kDa (TDP-43) within the CNS is a pathological hallmark in sporadic ALS and prion-like propagation of pathogenic TDP-43 is thought to be implicated in disease progression. However, cell-to-cell transmission of pathogenic TDP-43 in the human CNS has not been confirmed experimentally. Here we used induced pluripotent stem cells (iPSCs)-derived cerebral organoids as recipient CNS tissue model that are anatomically relevant human brain. We injected postmortem spinal cord protein extracts individually from three non-ALS or five sporadic ALS patients containing pathogenic TDP-43 into the cerebral organoids to validate the templated propagation and spreading of TDP-43 pathology in human CNS tissue. We first demonstrated that the administration of spinal cord extracts from an ALS patient induced the formation of TDP-43 pathology that progressively spread in a time-dependent manner in cerebral organoids, suggesting that pathogenic TDP-43 from ALS functioned as seeds and propagated cell-to-cell to form de novo TDP-43 pathology. We also reported that the administration of ALS patient-derived protein extracts caused astrocyte proliferation to form astrogliosis in cerebral organoids, reproducing the pathological feature seen in ALS. Moreover, we showed pathogenic TDP-43 induced cellular apoptosis and that TDP-43 pathology correlated with genomic damage due to DNA double-strand breaks. Thus, our results provide evidence that patient-derived pathogenic TDP-43 can mimic the prion-like propagation of TDP-43 pathology in human CNS tissue. Our findings indicate that our assays with human cerebral organoids that replicate ALS pathophysiology have a promising strategy for creating readouts that could be used in future drug discovery efforts against ALS.
    MeSH term(s) Humans ; Amyotrophic Lateral Sclerosis/pathology ; Spinal Cord/metabolism ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Prions/metabolism ; Organoids/metabolism
    Chemical Substances DNA-Binding Proteins ; Prions
    Language English
    Publishing date 2023-02-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2186725-2
    ISSN 1553-7404 ; 1553-7390
    ISSN (online) 1553-7404
    ISSN 1553-7390
    DOI 10.1371/journal.pgen.1010606
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Association Between Sepsis and Microvascular Brain Injury.

    Ehlenbach, William J / Sonnen, Joshua A / Montine, Thomas J / Larson, Eric B

    Critical care medicine

    2019  Volume 47, Issue 11, Page(s) 1531–1538

    Abstract: Objectives: Many survivors of sepsis suffer long-term cognitive impairment, but the mechanisms of this association remain unknown. The objective of this study was to determine whether sepsis is associated with cerebral microinfarcts on brain autopsy.: ...

    Abstract Objectives: Many survivors of sepsis suffer long-term cognitive impairment, but the mechanisms of this association remain unknown. The objective of this study was to determine whether sepsis is associated with cerebral microinfarcts on brain autopsy.
    Design: Retrospective cohort study.
    Setting and subjects: Five-hundred twenty-nine participants of the Adult Changes in Thought, a population-based prospective cohort study of older adults carried out in Kaiser Permanente Washington greater than or equal to 65 years old without dementia at study entry and who underwent brain autopsy.
    Measurements and main results: Late-life sepsis hospitalization was identified using administrative data. We identified 89 individuals with greater than or equal to 1 sepsis hospitalization during study participation, 80 of whom survived hospitalization and died a median of 169 days after discharge. Thirty percent of participants with one or more sepsis hospitalization had greater than two microinfarcts, compared with 19% participants without (χ p = 0.02); 20% of those with sepsis hospitalization had greater than two microinfarcts in the cerebral cortex, compared with 10% of those without (χ p = 0.01). The adjusted relative risk of greater than two microinfarcts was 1.61 (95% CI, 1.01-2.57; p = 0.04); the relative risk for having greater than two microinfarcts in the cerebral cortex was 2.12 (95% CI, 1.12-4.02; p = 0.02). There was no difference in Braak stage for neurofibrillary tangles or consortium to establish a registry for Alzheimer's disease score for neuritic plaques between, but Lewy bodies were less significantly common in those with sepsis.
    Conclusions: Sepsis was specifically associated with moderate to severe vascular brain injury as assessed by microvascular infarcts. This association was stronger for microinfarcts within the cerebral cortex, with those who experienced severe sepsis hospitalization being more than twice as likely to have evidence of moderate to severe cerebral cortical injury in adjusted analyses. Further study to identify mechanisms for the association of sepsis and microinfarcts is needed.
    MeSH term(s) Aged ; Aged, 80 and over ; Autopsy ; Brain/pathology ; Brain Infarction/pathology ; Cohort Studies ; Female ; Hospitalization ; Humans ; Intracranial Arteriosclerosis/pathology ; Male ; Retrospective Studies ; Sepsis/epidemiology ; Washington/epidemiology
    Language English
    Publishing date 2019-08-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 197890-1
    ISSN 1530-0293 ; 0090-3493
    ISSN (online) 1530-0293
    ISSN 0090-3493
    DOI 10.1097/CCM.0000000000003924
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Analysis of the microglia transcriptome across the human lifespan using single cell RNA sequencing.

    Yaqubi, Moein / Groh, Adam M R / Dorion, Marie-France / Afanasiev, Elia / Luo, Julia Xiao Xuan / Hashemi, Hadi / Sinha, Sarthak / Kieran, Nicholas W / Blain, Manon / Cui, Qiao-Ling / Biernaskie, Jeff / Srour, Myriam / Dudley, Roy / Hall, Jeffery A / Sonnen, Joshua A / Arbour, Nathalie / Prat, Alexandre / Stratton, Jo Anne / Antel, Jack /
    Healy, Luke M

    Journal of neuroinflammation

    2023  Volume 20, Issue 1, Page(s) 132

    Abstract: Background: Microglia are tissue resident macrophages with a wide range of critically important functions in central nervous system development and homeostasis.: Method: In this study, we aimed to characterize the transcriptional landscape of ex vivo ...

    Abstract Background: Microglia are tissue resident macrophages with a wide range of critically important functions in central nervous system development and homeostasis.
    Method: In this study, we aimed to characterize the transcriptional landscape of ex vivo human microglia across different developmental ages using cells derived from pre-natal, pediatric, adolescent, and adult brain samples. We further confirmed our transcriptional observations using ELISA and RNAscope.
    Results: We showed that pre-natal microglia have a distinct transcriptional and regulatory signature relative to their post-natal counterparts that includes an upregulation of phagocytic pathways. We confirmed upregulation of CD36, a positive regulator of phagocytosis, in pre-natal samples compared to adult samples in situ. Moreover, we showed adult microglia have more pro-inflammatory signature compared to microglia from other developmental ages. We indicated that adult microglia are more immune responsive by secreting increased levels of pro-inflammatory cytokines in response to LPS treatment compared to the pre-natal microglia. We further validated in situ up-regulation of IL18 and CXCR4 in human adult brain section compared to the pre-natal brain section. Finally, trajectory analysis indicated that the transcriptional signatures adopted by microglia throughout development are in response to a changing brain microenvironment and do not reflect predetermined developmental states.
    Conclusion: In all, this study provides unique insight into the development of human microglia and a useful reference for understanding microglial contribution to developmental and age-related human disease.
    MeSH term(s) Humans ; Child ; Adolescent ; Transcriptome ; Microglia/metabolism ; Longevity ; Phagocytosis ; Sequence Analysis, RNA
    Language English
    Publishing date 2023-05-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 2156455-3
    ISSN 1742-2094 ; 1742-2094
    ISSN (online) 1742-2094
    ISSN 1742-2094
    DOI 10.1186/s12974-023-02809-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Microinfarcts are common and strongly related to dementia in the oldest-old: The 90+ study.

    Corrada, María M / Sonnen, Joshua A / Kim, Ronald C / Kawas, Claudia H

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    2016  Volume 12, Issue 8, Page(s) 900–908

    Abstract: Introduction: We estimated the prevalence of microinfarcts and their association with dementia in a cohort of oldest-old participants.: Methods: Participants were from The 90+ Study, a population-based study of people 90 years and older. Dementia ... ...

    Abstract Introduction: We estimated the prevalence of microinfarcts and their association with dementia in a cohort of oldest-old participants.
    Methods: Participants were from The 90+ Study, a population-based study of people 90 years and older. Dementia diagnoses were assigned postmortem during a consensus conference. Microinfarcts were evaluated in six brain regions.
    Results: At death, the 213 participants were on average 97 years old, 69% were women, and 52% had dementia. Of the participants, 51% had microinfarcts and 17% had 3+ microinfarcts. The odds ratio (OR) for dementia was similar for 3+ microinfarcts (OR = 4.75, P < .01) and tangle stage V-VI (OR = 4.70, P < .001). Only microinfarcts in cortical regions (other than occipital) were associated to dementia.
    Discussion: In this oldest-old cohort, microinfarcts are common and contribute independently and similarly in magnitude to dementia as tangles. As risk factors for microinfarcts and other dementing pathologies are likely to differ, identifying these factors is crucial to developing prevention strategies for dementia in the oldest-old.
    MeSH term(s) Aged, 80 and over ; Aging/pathology ; Brain Infarction/etiology ; Cohort Studies ; Dementia/complications ; Dementia/pathology ; Female ; Humans ; Male
    Language English
    Publishing date 2016-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2211627-8
    ISSN 1552-5279 ; 1552-5260
    ISSN (online) 1552-5279
    ISSN 1552-5260
    DOI 10.1016/j.jalz.2016.04.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

    Cohen, Jordana B / Marcum, Zachary A / Zhang, Chong / Derington, Catherine G / Greene, Tom H / Ghazi, Lama / Herrick, Jennifer S / King, Jordan B / Cheung, Alfred K / Bryan, Nick / Supiano, Mark A / Sonnen, Joshua A / Weintraub, William S / Scharfstein, Daniel / Williamson, Jeff / Pajewski, Nicholas M / Bress, Adam P

    JAMA network open

    2022  Volume 5, Issue 7, Page(s) e2220680

    Abstract: Importance: The cardiovascular and renal outcomes of angiotensin-II receptor blocker (ARB) and angiotensin-converting enzyme inhibitor (ACEI) treatment are well-known; however, few studies have evaluated initiation of these agents and cognitive ... ...

    Abstract Importance: The cardiovascular and renal outcomes of angiotensin-II receptor blocker (ARB) and angiotensin-converting enzyme inhibitor (ACEI) treatment are well-known; however, few studies have evaluated initiation of these agents and cognitive impairment.
    Objective: To emulate a target trial to evaluate the cognitive outcomes of initiating an ARB- vs ACEI-based antihypertensive regimen in individuals at risk for mild cognitive impairment (MCI) and probable dementia (PD).
    Design, setting, and participants: Active comparator, new-user observational cohort study design using data from the Systolic Blood Pressure Intervention Trial (SPRINT), conducted November 2010 through July 2018. Marginal cause-specific hazard ratios (HRs) and treatment-specific cumulative incidence functions were estimated with inverse probability (IP) weighting to account for confounding. Participants were using neither an ARB nor ACEI at baseline. Data analysis was conducted from April 7, 2021, to April 26, 2022.
    Exposures: New users of ARB vs ACEI during the first 12 months of trial follow-up.
    Main outcomes and measures: Composite of adjudicated amnestic MCI or PD.
    Results: Of 9361 participants, 727 and 1313 new users of an ARB or ACEI, respectively, with well-balanced baseline characteristics between medication exposure groups after inverse probability weighting (mean [SD] age, 67 [9.5] years; 1291 ]63%] male; 240 [33%] Black; 89 [12%] Hispanic; 383 [53%] White; and 15 [2%] other race or ethnicity. In the primary analysis, during a median follow-up of 4.9 years, the inverse probability-weighted rate of amnestic MCI or PD was 4.3 vs 4.6 per 100 person-years among participants initiating ARB vs ACEI (HR, 0.93; 95% CI, 0.76-1.13). In subgroup analyses, new users of an ARB vs ACEI had a lower rate of amnestic MCI or PD among those in the standard systolic blood pressure treatment arm (HR, 0.61; 95% CI, 0.41-0.91) but not in the intensive arm (HR, 1.17; 95% CI, 0.90-1.52) (P = .007 for interaction).
    Conclusions and relevance: In this observational cohort study of US adults at high cardiovascular disease risk, there was no difference in the rate of amnestic MCI or PD among new users of an ARB compared with ACEI, although 95% CIs were wide.
    MeSH term(s) Adult ; Aged ; Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Blood Pressure ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/epidemiology ; Dementia/drug therapy ; Dementia/epidemiology ; Female ; Humans ; Male ; Proportional Hazards Models
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors
    Language English
    Publishing date 2022-07-01
    Publishing country United States
    Document type Journal Article ; Observational Study ; Research Support, N.I.H., Extramural
    ISSN 2574-3805
    ISSN (online) 2574-3805
    DOI 10.1001/jamanetworkopen.2022.20680
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Theoretical impact of the AT(N) framework on dementia using a community autopsy sample.

    Burke, Bridget Teevan / Latimer, Caitlin / Keene, C Dirk / Sonnen, Joshua A / McCormick, Wayne / Bowen, James D / McCurry, Susan M / Larson, Eric B / Crane, Paul K

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    2021  Volume 17, Issue 12, Page(s) 1879–1891

    Abstract: ... We used Consortium to Establish a Registry for Alzheimer's Disease (moderate/frequent) to approximate A+ ...

    Abstract The AT(N) research framework categorizes eight biomarker profiles using amyloid (A), tauopathy (T), and neurodegeneration (N), regardless of dementia status. We evaluated associations with dementia risk in a community-based cohort by approximating AT(N) profiles using autopsy-based neuropathology correlates, and considered cost implications for clinical trials for secondary prevention of dementia based on AT(N) profiles. We used Consortium to Establish a Registry for Alzheimer's Disease (moderate/frequent) to approximate A+, Braak stage (IV-VI) for T+, and temporal pole lateral ventricular dilation for (N)+. Outcomes included dementia prevalence at death and incidence in the last 5 years of life. A+T+(N)+ was the most common profile (31%). Dementia prevalence ranged from 14% (A-T-[N]-) to 79% (A+T+[N]+). Between 8% (A+T-[N]-) and 68% (A+T+[N]-) of decedents developed incident dementia in the last 5 years of life. Clinical trials would incur substantial expense to characterize AT(N). Many people with biomarker-defined preclinical Alzheimer's disease will never develop clinical dementia during life, highlighting resilience to clinical expression of AD neuropathologic changes and the need for improved tools for prediction beyond current AT(N) biomarkers.
    MeSH term(s) Aged ; Aged, 80 and over ; Autopsy ; Biomarkers ; Brain/pathology ; Cohort Studies ; Dementia/pathology ; Female ; Humans ; Male ; Neurofibrillary Tangles/pathology ; Neuropathology ; Plaque, Amyloid/pathology ; Positron-Emission Tomography ; Secondary Prevention
    Chemical Substances Biomarkers
    Language English
    Publishing date 2021-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2211627-8
    ISSN 1552-5279 ; 1552-5260
    ISSN (online) 1552-5279
    ISSN 1552-5260
    DOI 10.1002/alz.12348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: MicroRNA-210 regulates the metabolic and inflammatory status of primary human astrocytes.

    Kieran, Nicholas W / Suresh, Rahul / Dorion, Marie-France / MacDonald, Adam / Blain, Manon / Wen, Dingke / Fuh, Shih-Chieh / Ryan, Fari / Diaz, Roberto J / Stratton, Jo Anne / Ludwin, Samuel K / Sonnen, Joshua A / Antel, Jack / Healy, Luke M

    Journal of neuroinflammation

    2022  Volume 19, Issue 1, Page(s) 10

    Abstract: Background: Astrocytes are the most numerous glial cell type with important roles in maintaining homeostasis and responding to diseases in the brain. Astrocyte function is subject to modulation by microRNAs (miRs), which are short nucleotide strands ... ...

    Abstract Background: Astrocytes are the most numerous glial cell type with important roles in maintaining homeostasis and responding to diseases in the brain. Astrocyte function is subject to modulation by microRNAs (miRs), which are short nucleotide strands that regulate protein expression in a post-transcriptional manner. Understanding the miR expression profile of astrocytes in disease settings provides insight into the cellular stresses present in the microenvironment and may uncover pathways of therapeutic interest.
    Methods: Laser-capture microdissection was used to isolate human astrocytes surrounding stroke lesions and those from neurological control tissue. Astrocytic miR expression profiles were examined using quantitative reverse transcription polymerase chain reaction (RT-qPCR). Primary human fetal astrocytes were cultured under in vitro stress conditions and transfection of a miR mimic was used to better understand how altered levels of miR-210 affect astrocyte function. The astrocytic response to stress was studied using qPCR, enzyme-linked immunosorbent assays (ELISAs), measurement of released lactate, and Seahorse.
    Results: Here, we measured miR expression levels in astrocytes around human ischemic stroke lesions and observed differential expression of miR-210 in chronic stroke astrocytes compared to astrocytes from neurological control tissue. We also identified increased expression of miR-210 in mouse white matter tissue around middle cerebral artery occlusion (MCAO) brain lesions. We aimed to understand the role of miR-210 in primary human fetal astrocytes by developing an in vitro assay of hypoxic, metabolic, and inflammatory stresses. A combination of hypoxic and inflammatory stresses was observed to upregulate miR-210 expression. Transfection with miR-210-mimic (210M) increased glycolysis, enhanced lactate export, and promoted an anti-inflammatory transcriptional and translational signature in astrocytes. Additionally, 210M transfection resulted in decreased expression of complement 3 (C3) and semaphorin 5b (Sema5b).
    Conclusions: We conclude that miR-210 expression in human astrocytes is modulated in response to ischemic stroke disease and under in vitro stress conditions, supporting a role for miR-210 in the astrocytic response to disease conditions. Further, the anti-inflammatory and pro-glycolytic impact of miR-210 on astrocytes makes it a potential candidate for further research as a neuroprotective agent.
    MeSH term(s) Animals ; Astrocytes/metabolism ; HeLa Cells ; Humans ; Inflammation/genetics ; Inflammation/metabolism ; Laser Capture Microdissection ; Mice ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Stroke/genetics ; Stroke/metabolism
    Chemical Substances MicroRNAs
    Language English
    Publishing date 2022-01-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 2156455-3
    ISSN 1742-2094 ; 1742-2094
    ISSN (online) 1742-2094
    ISSN 1742-2094
    DOI 10.1186/s12974-021-02373-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Human Oligodendrocyte Myelination Potential; Relation to Age and Differentiation.

    Luo, Julia Xiao Xuan / Cui, Qiao-Ling / Yaqubi, Moein / Hall, Jeffery A / Dudley, Roy / Srour, Myriam / Addour, Nassima / Jamann, Hélène / Larochelle, Catherine / Blain, Manon / Healy, Luke M / Stratton, Jo Anne / Sonnen, Joshua A / Kennedy, Timothy E / Antel, Jack P

    Annals of neurology

    2022  Volume 91, Issue 2, Page(s) 178–191

    Abstract: Objective: Myelin regeneration in the human central nervous system relies on progenitor cells within the tissue parenchyma, with possible contribution from previously myelinating oligodendrocytes (OLs). In multiple sclerosis, a demyelinating disorder, ... ...

    Abstract Objective: Myelin regeneration in the human central nervous system relies on progenitor cells within the tissue parenchyma, with possible contribution from previously myelinating oligodendrocytes (OLs). In multiple sclerosis, a demyelinating disorder, variables affecting remyelination efficiency include age, severity of initial injury, and progenitor cell properties. Our aim was to investigate the effects of age and differentiation on the myelination potential of human OL lineage cells.
    Methods: We derived viable primary OL lineage cells from surgical resections of pediatric and adult brain tissue. Ensheathment capacity using nanofiber assays and transcriptomic profiles from RNA sequencing were compared between A2B5+ antibody-selected progenitors and mature OLs (non-selected cells).
    Results: We demonstrate that pediatric progenitor and mature cells ensheathed nanofibers more robustly than did adult progenitor and mature cells, respectively. Within both age groups, the percentage of fibers ensheathed and ensheathment length per fiber were greater for A2B5+ progenitors. Gene expression of OL progenitor markers PDGFRA and PTPRZ1 were higher in A2B5+ versus A2B5- cells and in pediatric A2B5+ versus adult A2B5+ cells. The p38 MAP kinases and actin cytoskeleton-associated pathways were upregulated in pediatric cells; both have been shown to regulate OL process outgrowth. Significant upregulation of "cell senescence" genes was detected in pediatric samples; this could reflect their role in development and the increased susceptibility of pediatric OLs to activating cell death responses to stress.
    Interpretation: Our findings identify specific biological pathways relevant to myelination that are differentially enriched in human pediatric and adult OL lineage cells and suggest potential targets for remyelination enhancing therapies. ANN NEUROL 2022;91:178-191.
    MeSH term(s) Adult ; Aging/physiology ; Cell Death ; Cell Differentiation/physiology ; Cell Lineage ; Cellular Senescence/physiology ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Middle Aged ; Myelin Sheath/physiology ; Neural Stem Cells ; Oligodendroglia/physiology ; RNA-Seq ; Receptor, Platelet-Derived Growth Factor alpha ; Receptor-Like Protein Tyrosine Phosphatases, Class 5/genetics ; Transcriptome ; Young Adult
    Chemical Substances Receptor, Platelet-Derived Growth Factor alpha (EC 2.7.10.1) ; PTPRZ1 protein, human (EC 3.1.3.48) ; Receptor-Like Protein Tyrosine Phosphatases, Class 5 (EC 3.1.3.48)
    Language English
    Publishing date 2022-01-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.26288
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top